Page last updated: 2024-08-24

valsartan and eicosapentaenoic acid ethyl ester

valsartan has been researched along with eicosapentaenoic acid ethyl ester in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Haslam, A; Prasad, V1

Other Studies

1 other study(ies) available for valsartan and eicosapentaenoic acid ethyl ester

ArticleYear
Confirmatory Trials for Drugs Approved on a Single Trial.
    Circulation. Cardiovascular quality and outcomes, 2019, Volume: 12, Issue:6

    Topics: Aminobutyrates; Angiotensin II Type 1 Receptor Blockers; Biphenyl Compounds; Cardiovascular Diseases; Clinical Trials as Topic; Dietary Supplements; Drug Approval; Drug Combinations; Eicosapentaenoic Acid; Evidence-Based Medicine; Heart Failure; Humans; Neprilysin; Protease Inhibitors; Research Design; Tetrazoles; Treatment Outcome; Valsartan

2019